Evidence map›Paper›PMID 32213075›Full record

ArticleUnited European gastroenterology journal2020

Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study.

Idan Goren, Adi Brom, Henit Yanai, Amir Dagan, Gad Segal, Ariel Israel

Open access · bronzeAbstract read
In one paragraph

Article in United European gastroenterology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Journal of medical cases · 2022
    Article
  10. Article
  11. The role of oral bacteria in inflammatory bowel disease.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Idan GorenDivision of Gastroenterology, Rabin Medical Center * , Petah Tikva, Israel.ORCID 0000-0002-2162-2840
Adi BromInternal Medicine T, Chaim Sheba Medical Center * , Tel-Hashomer, Ramat-Gan, Israel.
Henit YanaiDivision of Gastroenterology, Rabin Medical Center * , Petah Tikva, Israel.
Amir DaganRheumatology Unit, Assuta Medical Center, Ashdod, Israel.
Gad SegalInternal Medicine T, Chaim Sheba Medical Center * , Tel-Hashomer, Ramat-Gan, Israel.
Ariel IsraelClalit Jerusalem Research Center, Clalit Health Services, Jerusalem, Israel.
Rabin Medical Center · ILSheba Medical Center · ILAssuta Medical Center · ILEquality Now · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with inflammatory bowel disease might be at increased risk of invasive bacterial infections.

objectivesThe objective of this study was to identify the rate of bacteremia in hospitalised patients with inflammatory bowel disease and risk factors.

methodsAn observational cohort of hospitalised patients with inflammatory bowel disease, aged 16-80 years, from 2008 to 2017 in a large tertiary hospital. Patients with Charlson comorbidity index of 2 or greater were excluded. Patients with one or more positive blood culture were reviewed. Logistic regression was used to evaluate risk factors for bacteremia.

resultsOf 5522 admitted patients, only 1.3% had bacteremia (73/5522) (39, Crohn's disease; 25, ulcerative colitis; nine, unclassified inflammatory bowel disease). The most common pathogen was

conclusionAge over 65 years, but not inflammatory bowel disease-related medications, is associated with an increased risk of bacteremia in hospitalised patients with inflammatory bowel disease.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsBacteremiaColitis, UlcerativeCrohn DiseaseFemaleHumansImmunosuppressive AgentsLength of StayMaleMiddle AgedRetrospective StudiesRisk FactorsImmunosuppressive AgentsTNF protein, humanTumor Necrosis Factor-alphaanti-TNFbacteremiaCrohn’s diseasehospitalizationInflammatory bowel diseaserisk factorsulcerative colitis

Identifiers

PMID32213075
PMCPMC7079278
OpenAlexW2971794906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.